国邦医药

- 605507

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017 
国邦医药(605507) 利润表
单位:万元
报表日期2021-12-312021-09-302021-06-302021-03-31
一、营业总收入450,535.06321,320.15224,239.62114,226.59
营业收入450,535.06321,320.15224,239.62114,226.59
二、营业总成本366,539.06260,516.70180,346.2391,643.67
营业成本314,762.19221,895.28155,257.4980,146.44
营业税金及附加2,507.211,834.441,178.58633.47
销售费用5,586.475,517.083,361.821,476.94
管理费用25,350.6518,567.6411,652.885,574.53
财务费用2,805.382,081.082,051.70515.99
研发费用15,527.1710,621.196,843.763,296.29
资产减值损失--------
公允价值变动收益625.71-----16.71
投资收益427.5798.68-41.82-44.54
其中:对联营企业和合营企业的投资收益-156.08-59.47-59.47-19.15
汇兑收益--------
三、营业利润80,877.4359,708.2043,976.9522,123.15
加:营业外收入966.701,003.56160.32108.01
减:营业外支出1,165.96603.19434.92185.18
其中:非流动资产处置损失--------
四、利润总额80,678.1760,108.5743,702.3622,045.98
减:所得税费用10,055.217,943.685,899.153,510.05
五、净利润70,622.9652,164.8937,803.2118,535.93
归属于母公司所有者的净利润70,603.0352,108.3637,769.0818,510.03
少数股东损益19.9256.5334.1225.89
六、每股收益
基本每股收益(元/股)1.38001.06000.80000.3900
稀释每股收益(元/股)1.38001.06000.80000.3900
七、其他综合收益--------
八、综合收益总额70,622.9652,164.8937,803.2118,535.93
归属于母公司所有者的综合收益总额70,603.0352,108.3637,769.0818,510.03
归属于少数股东的综合收益总额19.9256.5334.1225.89
下载全部历史数据到excel中 返回页顶